Views: 22 Author: Site Editor Publish Time: 2026-08-17 Origin: Site
HbA1c testing plays an important role in diabetes screening, diagnosis, and long-term glycemic management. Unlike a blood glucose test, which provides a snapshot of glucose concentration at a specific point in time, HbA1c reflects the body's exposure to glucose over a longer period.
High-Performance Liquid Chromatography (HPLC) is one of the established analytical technologies used for HbA1c measurement. By separating different hemoglobin fractions before quantification, HPLC can provide both a numerical HbA1c result and a chromatographic profile of hemoglobin components.
In this article, we explain the principle, testing workflow, chromatogram, calculation, advantages, and limitations of HPLC HbA1c testing.
HbA1c, or glycated hemoglobin, is a form of hemoglobin produced when glucose in the blood becomes irreversibly attached to hemoglobin. According to the IFCC definition, HbA1c is hemoglobin that is irreversibly glycated at one or both N-terminal valines of the beta chains.
Because hemoglobin is contained within red blood cells and red blood cells normally circulate for approximately 120 days, HbA1c provides information about glucose exposure over the preceding weeks to months.
In simple terms:
Higher average glucose exposure → More hemoglobin glycation → Higher HbA1c
For this reason, HbA1c is widely used to assess long-term glycemic control.
However, HbA1c is not a direct measurement of blood glucose. Conditions that affect red blood cell survival or hemoglobin composition can influence HbA1c results or their interpretation.
HPLC stands for High-Performance Liquid Chromatography. The fundamental principle of HPLC HbA1c testing is based on the separation of different hemoglobin fractions according to their physicochemical properties and interactions with the chromatographic column. In many HbA1c systems, ion-exchange chromatography is used.
During analysis, the hemoglobin sample passes through a chromatographic column containing a stationary phase. Different hemoglobin fractions interact with the column to different degrees and therefore leave the column at different times. This process is called elution. The separated hemoglobin fractions are then detected, generating a characteristic chromatogram.
The basic analytical concept can therefore be summarized as:
Sample → Hemoglobin Separation → Detection → Chromatogram → HbA1c Quantification
The complete HbA1c testing process can be divided into several major steps.
HbA1c testing is generally performed using anticoagulated whole blood.
A commonly used specimen is EDTA-anticoagulated whole blood.
The majority of hemoglobin is contained inside red blood cells, so the first objective of the analytical process is to release the hemoglobin from the cells.
The red blood cells are lysed to release hemoglobin into the sample solution.
After lysis, the analytical system contains the hemoglobin fractions that need to be separated and measured.
Depending on the sample, these may include:
HbA0
HbA1c
HbA2
HbF
Other hemoglobin fractions
Potential hemoglobin variants
This step prepares the sample for chromatographic analysis.
A defined amount of the prepared hemoglobin sample is introduced into the HPLC flow path.
The mobile phase carries the sample toward the chromatographic column.
Precise sample handling and injection are important because variations at this stage can affect analytical reproducibility.
This is the core principle of HPLC HbA1c testing.
Inside the chromatographic column, different hemoglobin fractions interact differently with the stationary phase.
As the mobile phase passes through the column:
Different interactions → Different retention times → Separation of hemoglobin fractions
HbA1c can therefore be separated from HbA0 and other hemoglobin fractions.
The exact retention time and peak pattern depend on the specific analyzer, column chemistry, mobile phase, reagents, and analytical method. This is an important point: there is no universal chromatogram pattern that applies identically to every HPLC HbA1c analyzer.
After chromatographic separation, the detector continuously records the signal from the eluted hemoglobin fractions. The result is a chromatogram. A simplified chromatogram may contain peaks corresponding to different fractions such as:
HbF → HbA1c → HbA0 → HbA2
Each peak represents a separated component or fraction, and the area under the peak is related to the amount of that component detected. The chromatogram therefore provides two important types of information:
How much HbA1c is present relative to the relevant total hemoglobin?
Does the chromatogram show an unusual peak, abnormal fraction, or unexpected pattern?
This second aspect is one of the important characteristics of chromatographic HbA1c testing.
Following chromatographic separation, the analyzer identifies and integrates the HbA1c fraction. Conceptually, HbA1c can be expressed as:
HbA1c (%) = HbA1c peak area ÷ Total reportable Hb peak area × 100%
For example, if the relevant HbA1c peak represents approximately 7% of the total reportable hemoglobin peak area, the HbA1c result would be approximately: HbA1c = 7.0%
The actual calculation, peak boundaries, integration rules, and reportable fractions are determined by the specific validated analytical method.
Therefore, HPLC HbA1c testing is not simply a measurement of peak height. It involves:
Peak separation → Peak identification → Peak integration → Quantification → Result reporting
The fundamental advantage of HPLC is its ability to separate different hemoglobin fractions before quantification. Instead of measuring the sample as a single undifferentiated signal, the analyzer separates components according to their chromatographic behavior. This provides a more detailed analytical view of the hemoglobin sample.
After separation, the HbA1c fraction can be quantified based on its relative peak area. This provides a direct analytical pathway from:
Chromatographic separation → HbA1c peak → Peak integration → HbA1c percentage
HPLC generates a chromatogram rather than only a final numerical result. Laboratory professionals can review the overall chromatographic pattern and identify unusual peaks or unexpected fractions. This additional information can be valuable when investigating samples with potentially abnormal hemoglobin patterns.
Some HPLC HbA1c systems can provide useful information about certain hemoglobin variants based on their retention characteristics and chromatographic patterns. This can be particularly relevant in populations with a relatively high prevalence of hemoglobinopathies or thalassemia.
However, the ability to detect or quantify individual hemoglobin variants is method-specific. Different HbA1c methods may respond differently to HbS, HbC, HbE, HbD, elevated HbF, and other hemoglobin-related factors.
The performance of an HbA1c analyzer depends not only on its analytical technology but also on calibration, quality control, standardization, reagent performance, software, and method validation.
The ADA 2026 Standards of Care recommends that HbA1c used for diabetes diagnosis should be measured using a method that is NGSP-certified and standardized to the DCCT reference assay.
The NGSP standardization program is designed to harmonize HbA1c results with established reference systems, while the IFCC has established an international reference system for HbA1c measurement. This standardization is essential because a clinically meaningful HbA1c result requires more than analytical precision alone.
HPLC is not the only technology used for HbA1c testing. Other analytical approaches include:
Immunoassay
Boronate affinity chromatography
Enzymatic assays
Other chromatographic methods
Each method has its own analytical principle and interference profile. For example:
HPLC: Separates hemoglobin fractions chromatographically before quantification.
Immunoassay: Uses antibody-based recognition of glycated hemoglobin.
Boronate affinity: Uses the affinity between boronic acid and glycated structures.
Enzymatic methods: Use enzymatic reactions to quantify glycated hemoglobin-related components.
HbA1c is a valuable biomarker, but it is not completely free from biological or analytical interference. According to NGSP, factors such as hemoglobin variants, elevated HbF, chemically modified hemoglobin derivatives, and conditions that alter red blood cell survival can affect HbA1c measurement or interpretation. The degree of interference depends on the specific factor and the analytical method. For example, conditions that shorten red blood cell survival can lead to a lower HbA1c result regardless of the analytical method.
Potential factors include:
Hemolytic anemia
Recent blood loss
Recent blood transfusion
Conditions affecting erythrocyte turnover
Certain hemoglobin variants
Elevated HbF
Certain renal conditions
Other clinical conditions affecting the relationship between HbA1c and glycemia
The ADA recommends considering possible interference when HbA1c results are substantially discordant with blood glucose measurements. Therefore, HbA1c results should always be interpreted together with the patient's clinical information and other laboratory findings.
One particularly interesting application of HPLC is its ability to provide chromatographic information about hemoglobin fractions. In some systems, abnormal chromatographic patterns may support further investigation of:
β-thalassemia
Elevated HbF
Sickle cell-related hemoglobin variants
Other hemoglobin abnormalities
However, HbA1c HPLC is not equivalent to a dedicated hemoglobinopathy diagnostic test. When a hemoglobin abnormality is suspected, confirmatory testing may include hematological parameters, hemoglobin electrophoresis, capillary electrophoresis, molecular testing, or other appropriate methods. This distinction is important for both laboratories and clinicians.
The entire process can be summarized in a simple workflow:
This workflow transforms a whole-blood sample into both a quantitative HbA1c result and a chromatographic hemoglobin profile.
When evaluating an HPLC HbA1c analyzer, laboratories should look beyond the basic statement that the system uses HPLC.
Important factors include:
Accuracy, precision, linearity, reportable range, and analytical stability are fundamental.
The method should have appropriate calibration and traceability to recognized HbA1c reference systems.
Good separation between relevant hemoglobin fractions is essential for reliable peak identification and interpretation.
The system should have clearly characterized performance with relevant hemoglobin variants and other potential interferents.
Sample loading, throughput, reagent management, maintenance, and result reporting all affect laboratory efficiency.
A clear chromatogram can help laboratory professionals quickly recognize normal and abnormal patterns.
For laboratories, the best system is therefore not simply the one with the most advanced technology, but the one that combines analytical performance, standardization, reliability, usability, and appropriate clinical application.
The value of HPLC lies in its ability to turn a complex hemoglobin sample into structured analytical information. Rather than simply asking:
“What is the HbA1c value?”
HPLC also helps answer:
“What does the hemoglobin profile look like?”
This separation-based approach can provide laboratories with additional information when reviewing HbA1c results, particularly when unusual chromatographic patterns are encountered.
As diabetes continues to increase worldwide, reliable HbA1c testing remains an important component of laboratory medicine and diabetes management.
HPLC HbA1c testing combines chromatographic separation, detection, peak analysis, and standardized quantification to measure glycated hemoglobin.
The process can be summarized as: Separate → Detect → Quantify → Interpret
Its major analytical value is that it can provide both a quantitative HbA1c result and a chromatographic profile of hemoglobin fractions.
For laboratories, reliable HbA1c testing requires more than the use of HPLC technology alone. Standardization, traceability, calibration, quality control, analytical performance, and method-specific interference assessment are all essential.
At Medlere, we believe advanced diagnostic technology should not make healthcare more complicated. It should make reliable laboratory information more accessible, understandable, and actionable.
Learn more about HPLC HbA1c testing and explore the M3 HPLC HbA1c Analyzer →
American Diabetes Association. Standards of Care in Diabetes—2026: Diagnosis and Classification of Diabetes. Diabetes Care, 2026.
National Glycohemoglobin Standardization Program (NGSP). Factors that Interfere with HbA1c Test Results. Updated June 23, 2026.
National Glycohemoglobin Standardization Program (NGSP). IFCC Standardization of HbA1c.
National Glycohemoglobin Standardization Program (NGSP). NGSP Home and HbA1c Standardization Information.
